Is the Fourth Time the Charm for This Antidepressant?
An FDA advisory committee is considering the fate of gepirone, which was rejected by the agency in 2002, 2004, and 2007.
All articles by Jonathan Block
Parental Death In Childhood Raises Suicide Risk
Suicide risk may be strongly influenced by events that happen early in life.
Faulty Brain Cells Implicated As Possible Depression Cause
Malfunctioning microglia can cause depression, but drugs that restore the normal functioning of them can be as effective as antidepressants.
CBT Program Benefits Youth At Risk for Depression For Years
Teens who had one parent with depression who took part in a cognitive-behavioral prevention program were less likely to develop depression.
APA Asks Federal, State Officials to Examine Anthem, Cigna Merger
The APA is concerned that the merger will strengthen the insurers’ buying power of psychiatric services to patients’ detriment.
Males, Females With Autism Score Same on Inference Test
Results bolster the “extreme male brain” theory of autism.
Shortage of Psychiatrists Only Getting Worse
From 1995 to 2013, the number of psychiatrists in the U.S. increased by just 12%.
Biogen’s Aducanumab Offers Mixed Results in Alzheimer’s Progression
The big question now is what doses will Biogen examine in aducanumab phase 3 trials.
Caffeine May Help To Maintain Memory, Inhibit Cognitive Impairment
Greater intake of caffeine among healthy older adults was associated with better memory and executive functioning.
Majority of Dementia Patients Take Multiple Psychotropic Drugs
Dementia patients who were younger, female and lived in nursing homes were most associated with psychotropic polypharmacy.
Next post in AAIC 2015 Coverage
